Abstract Objectives: Extracorporeal membrane oxygenation (ECMO) systems have continued to evolve and improve with the development of smaller and portable systems. The Cardiohelp (Maquet Getinge Cardiopulmonary AG, Rastatt, Germany) portable..
Read More
Abstract Background. Temporary extracorporeal membrane oxygenation (ECMO) support for high-risk percutaneous coronary intervention (PCI) has been described in select patients, and data are limited on the CardioHELP device (Maquet). The..
Read More
Abstract Extracorporeal membrane oxygenation (ECMO) is a last resort therapy for patients with terminal respiratory failure. In the current worldwide surge of critically ill patients with novel coronavirus disease (COVID-19),..
Read More
Abstract Introduction: Extracorporeal life support (ECLS) patients are at risk for complications caused by gaseous microemboli (GME). GMEs can cause hypoxia, inflammation, coagulation, and end-organ damage. The objective of this..
Read More
• Los dispositivos de normo-hipotermia controlan la temperatura de la sangre del paciente durante la perfusión extracorpórea. Son dispositivos no estériles que se emplean en el quirófano fuera del campo..
Read More
With critically ill or injured patients, there’s no time for delay. That’s why Getinge has long been committed to advancing ECLS technology. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/01/CARDIOHELP-SYSTEM.pdf" title="CARDIOHELP SYSTEM"]
Read More
MECC’s compact and less invasive approach has opened the door to concerted interaction between surgeon, perfusionist, and anaesthesiologist resulting in optimized patient management. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/01/MECC-i-FOR-CARDIOHELP-i.pdf" title="MECC-i FOR CARDIOHELP-i"]
Read More